Asahi Kasei Bioprocess America Revenue
Biotechnology Research • 
Glenview, Illinois, United States • 101-200 Employees
Asahi Kasei Bioprocess America revenue & valuation
| Annual revenue | $37,500,000 |
| Revenue per employee | $300,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $120,000,000 |
| Total funding | No funding |
Key Contacts at Asahi Kasei Bioprocess America
Eric Zhu
Director Of Business Development
Desiree Anastasia Henry
Creative Services Director
Cory Hinz
Director Of Engineering
Hirohisa Hayashida
S&T Director
Company overview
| Headquarters | 1855 Elmdale Ave., Glenview, IL 60026, US |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Keywords | Process Automation, Hplc Systems, Chromatography Columns, Downstream Bioprocessing, Oligonucleotide Synthesis And Synthesizers, Virus Filtration, Cleavage And Deprotection Systems, Inline Buffer Dilution And Conditioning, Motiv™ Inline Buffer Formulation Systems, Mplc Systems, Ocelot™ System Control, Synthesis Columns, Uhplc Systems |
| Employees | 101-200 |
| Socials |
Asahi Kasei Bioprocess America Email Formats
Asahi Kasei Bioprocess America uses 3 email formats. The most common is {first name}.{last name} (e.g., john.doe@ak-bio.com), used 72.8% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@ak-bio.com | 72.8% |
{first initial}.{last name} | j.doe@ak-bio.com | 25.9% |
{first initial}.{first initial} | j.j@ak-bio.com | 1.2% |
About Asahi Kasei Bioprocess America
As a global partner to the biopharmaceutical industry, Asahi Kasei Bioprocess helps biologics manufacturers safely and efficiently produce medicines that patients can trust, by dependably supplying innovative yet exceptionally reliable bioprocess consumables, equipment and scientific support services. Our portfolio is anchored by Planova™ virus removal filters. First released in 1989 as the world's first hollow fiber filter developed specifically for removing viruses from biotherapeutic drug products, Planova™ filters ensure viral safety of biopharmaceutical drug products, thanks to their high quality and consistent performance. Leveraging 30 years of experience, we continue to provide our customers with products, services and expertise to achieve assurance that is beyond expectation. As part of our dedication to solving therapeutic product safety, efficiency and purity challenges, we also manufacture a comprehensive suite of downstream equipment. With technology platforms for virus filtration, chromatography, inline buffer formulation and oligonucleotide synthesis, our bioprocessing systems, columns and automation solutions advance GMP manufacturing of critical drug substances around the world. Our portfolio of market-driven equipment and cutting-edge technology touches unit operations across a wide range of therapeutic modalities, including classical small molecule pharmaceuticals, current-generation antibodies, plasma derivatives and next-generation oligonucleotide therapeutics.
Employees by Management Level
Total employees: 101-200
Seniority
Employees
Employees by Department
Asahi Kasei Bioprocess America has 82 employees across 11 departments.
Departments
Number of employees
Funding Data
Asahi Kasei Bioprocess America has never raised funding before.
Asahi Kasei Bioprocess America Tech Stack
Discover the technologies and tools that power Asahi Kasei Bioprocess America's digital infrastructure, from frameworks to analytics platforms.
Web servers
Marketing automation
PaaS
CDN
Load balancers
JavaScript libraries
Tag managers
Cookie compliance
SSL/TLS certificate authorities
Font scripts
Korea, Republic of
Germany
Ireland
United Kingdom
New Zealand
Frequently asked questions
4.8
40,000 users
